These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 953963

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunocompetence, immunosuppression, and human breast cancer. II. Further evidence of initial immune impairment by integrated assessment effect of nodal involvement (N) and of primary tumor size (T).
    Adler A, Stein JA, Ben-Efraim S.
    Cancer; 1980 Apr 15; 45(8):2061-73. PubMed ID: 7370952
    [Abstract] [Full Text] [Related]

  • 3. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
    Mandeville R, Lamoureux G, Legault-Poisson S, Poisson R.
    Cancer; 1982 Oct 01; 50(7):1280-8. PubMed ID: 6980699
    [Abstract] [Full Text] [Related]

  • 4. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
    Adler A, Stein JA, Ben-Efraim S.
    Cancer; 1980 Apr 15; 45(8):2074-83. PubMed ID: 7370953
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ, Tarpley JL, Potvin C, Chretien PB.
    Clin Exp Immunol; 1975 Feb 15; 19(2):327-33. PubMed ID: 1082390
    [Abstract] [Full Text] [Related]

  • 7. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
    Das SN, Khanna NN, Khanna S.
    Ann Acad Med Singap; 1985 Apr 15; 14(2):374-81. PubMed ID: 3876055
    [Abstract] [Full Text] [Related]

  • 8. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
    Nemoto T, Han T, Minowada J, Angkur V, Chamberlain A, Dao L.
    J Natl Cancer Inst; 1974 Sep 15; 53(3):641-5. PubMed ID: 4606319
    [No Abstract] [Full Text] [Related]

  • 9. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M, Kovarík J, Hlávková J, Popelínský L, Lauerová L.
    Neoplasma; 1985 Sep 15; 32(1):45-50. PubMed ID: 3982560
    [Abstract] [Full Text] [Related]

  • 10. [Cellular immunity indices in benign breast tumors].
    Baisheva SA, Zhalgasbaeva GT, Kaliev IuSh, Mezinova NN.
    Vopr Onkol; 1980 Sep 15; 26(5):15-9. PubMed ID: 7385708
    [Abstract] [Full Text] [Related]

  • 11. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
    Obata N, Kodama S, Hando T, Hirogami T, Takeuchi S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May 15; 32(5):550-8. PubMed ID: 7240843
    [Abstract] [Full Text] [Related]

  • 12. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S, Rezkallah MT, Miki SS, Naspitz CK, Mendes NF.
    Cancer; 1976 Sep 15; 38(3):1149-54. PubMed ID: 1085193
    [Abstract] [Full Text] [Related]

  • 13. [The immune competence of patients with Crohn's disease (author's transl)].
    Tönnesmann E, Bürkle PA, Schäfer B, Federlin K.
    Klin Wochenschr; 1979 Oct 15; 57(20):1097-107. PubMed ID: 513603
    [Abstract] [Full Text] [Related]

  • 14. Delayed cutaneous hypersensitivity, lymphocyte count, and blood tests in patients with breast carcinoma.
    Lee YT.
    J Surg Oncol; 1984 Nov 15; 27(3):135-40. PubMed ID: 6492808
    [Abstract] [Full Text] [Related]

  • 15. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.
    Das SN, Khanna NN, Khanna S.
    Cancer Invest; 1986 Nov 15; 4(3):207-16. PubMed ID: 3719410
    [Abstract] [Full Text] [Related]

  • 16. Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters.
    Wanebo HJ, Rosen PP, Thaler T, Urban JA, Oettgen HF.
    Ann Surg; 1976 Sep 15; 184(3):258-67. PubMed ID: 962394
    [Abstract] [Full Text] [Related]

  • 17. Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity.
    Baskies AM, Chretien PB, Weiss JF, Makuch RW, Beveridge RA, Catalona WJ, Spiegel HE.
    Cancer; 1980 Jun 15; 45(12):3050-60. PubMed ID: 7388749
    [Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of general immune competence in breast cancer. II. Sequential pre- and post-treatment levels: a 10 year study.
    Shukla HS, Hughes LE, Whitehead RH, Newcombe RG.
    Cancer Immunol Immunother; 1986 Jun 15; 21(1):6-11. PubMed ID: 3632917
    [Abstract] [Full Text] [Related]

  • 19. Secondary immunodeficiency in miliary tuberculosis.
    Uberoi S, Malaviya AN, Chattopadhyay C, Kumar R, Shrinivas.
    Clin Exp Immunol; 1975 Dec 15; 22(3):404-8. PubMed ID: 1083782
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppression in Burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical status.
    Magrath IT, Simon RM.
    Int J Cancer; 1976 Oct 15; 18(4):399-408. PubMed ID: 977186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.